| Fund ID | 805-1625937139 |
| Fund type | Hedge Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | Yes |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | No |
| % of assets independently valued | 100% |
| Owned by the adviser or related persons | 13% |
| Owned by funds of funds | 29% |
| Owned by non-U.S. persons | 11% |
| Fund | Type | Gross assets |
|---|---|---|
| Driehaus Emerging Markets Fund, L.P. | Other Private | $359.3M |
| Driehaus Life Sciences (qp) Fund, L.P. | Hedge | $109.7M |
| Driehaus Associates Fund | Hedge | $9.5M |
Driehaus Life Sciences Master Fund, L.P. reports $302.3 million in gross assets, among the top 24% of private funds by size.
The stated minimum investment is $1 million.
Driehaus Life Sciences Master Fund, L.P. is managed by Driehaus Capital Management LLC.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.